Clinical Trials in Cleveland

Showing 10481-10500 of 16,969 trials

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

NCT02567656

The purpose of this study is to evaluate the safety, PK and efficacy of RP6530, a dual PI3K delta/gamma inhibitor in patients with relapsed and refractory T-cell Lymphoma.

Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, Cutaneous

Rhizen Pharmaceuticals SA58 participantsStarted Sep 2015

Duarte, California, United States • Orange, California, United States • Aurora, Colorado, United States +5 more locations

TERMINATEDPhase 3< 1 mile

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

NCT02556203

To assess whether a rivaroxaban-based anticoagulation strategy, following successful TAVR, compared to an antiplatelet-based strategy, is superior in reducing death or first thromboembolic events (DTE). To assess the primary bleeding events (PBE) of the rivaroxaban-based strategy compared to an antiplatelet-based strategy, following TAVR.

Transcatheter Aortic Valve Replacement

Bayer1,653 participantsStarted Dec 2015

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Clearwater, Florida, United States +137 more locations

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Find Trials by Condition in Cleveland

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

A Clinical Trial of The VisAbility Micro Insert System for Presbyopic Patients

Performance Assessment of a Modified Daily Disposable Contact Lens

Answer ALS: Individualized Initiative for ALS Discovery

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Radiesse® Safety Study For the Treatment of Hands

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia